chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About a month after getting the vaccine I started getting some weird headaches and brain fog. I took some over the counter medications for the headaches and the brain fog just went away. The brain fog lasted for about a month. About 2 weeks ago I had an allergy reaction. I have never had allergies like this before. I have been using Flonase. I also saw an allergist to see what is going on. They do not know what might have caused the allergies but they think the headaches and brain fog are correlated to the vaccine.
This spontaneous report was received from a pharmacist refers to an about 5-10 patients of unknown age and gender. Medical history was not reported. The pharmacist informed that in August 2014 the patients were vaccinated with ZOSTAVAX vial, subcutaneous (lot number, expiration date and dosage were not reported) which was improperly exposed to defrost cycling up to 7 F for <1 hour per cycle for 1 cycle per day each day. The date that this ZOSTAVAX was placed into this freezer was unspecified. No known adverse effects were reported. Follow up information has been received from a pharmacist refers to a 65 years old female patient with diabetes. On 05-AUG-2014, the patient was vaccinated with a dose of ZOSTAVAX subcutaneously, (lot# J016257, expiration date: 20-FEB-2015) in the left arm (circle one). This is one of several reports received from the same reporter. Additional information has been requested.
Headache, Myalgia & Arthralgia  Narrative:  Reaction 2/9-2/10 Sx: for 2 days after vaccine include: chills, headache, fatigue, myalgia, fatigue, and pain at injection site.  Other Relevant History:
Information has been received from a licensed practical nurse concerning a 6 months old patient of unknown gender who on 08-OCT-2014 was vaccinated with ROTATEQ (lot # J014868 expiration date 13-OCT-2015), oral (dose not reported). The vaccine was reported to have temperature excursions from 10-SEP-2014 to 12-SEP-2014. No adverse reports. This is one of several reports from the same source. Additional information is not expected because all follow ups requested to complete the case were received.
She reports it hurting a lot. She develop "significant bruising" at the injection site. "Raised, red, lumpy" area pt describes as below injection site. warmth and pain.
PT CALLED PHARMACY INQUIRING ABOUT 2ND DOSE OF COVID VACCINE. PT WAS TOLD OUR PHARMACY CARRIES MODERNA VACCINE AND WE WERE HOLDING A CLINIC ON 4/2/21 FROM 9 TO 3 PM WITH MODERNA VACCINE. PT CAME TO CLINIC RECEIVED DOSE AT APPROX 2:15 PM. UPON GETTING READY TO SIGN VACCINATION CARD SAW 1ST DOSE GIVEN WAS PFIZER ON 3/6/2021. MADE PT AWARE OF SITUATION EXPLAINING MAY NOT HAVE FULL COVERAGE SINCE DIFF VACCINES. NO ADVERSE SYMPTOMS REPORTED. PT EXPLAINED WAS MOVING TO TEXAS ON 4/3/21.
booster doses given > 12 hour post puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (booster doses given > 12 hour post puncture) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (booster doses given > 12 hour post puncture). On 04-Jan-2022, EXPIRED PRODUCT ADMINISTERED (booster doses given > 12 hour post puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  The doses were drawn up into syringes prior to administration. The patient's date of birth and previous COVID19 vaccinations were unknown.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-439461, MOD-2022-438972 (Patient Link).
Headache, Myalgia, NauseaVomiting,  chills, fatigue  Narrative:   Other Relevant History:
PD informed vaccination staff that patient called stating she fainted. No episodes of syncope/fainting were observed by vaccinator staff when patient was at the vaccination site.  Pt received 1st booster Pfizer dose at 1617. Pt did not wait full 30 minutes in observation as advised by vaccination staff. Pt left premises and was walking down the street when she called. RN called patient to check in. Pt reports that she is unsure if she fainted or not but she might have because she is sitting down. PD were notified by vaccination site staff and will go find patient.
died 2 days after getting that booster; blindness; serious cancers, like breast and liver cancer; serious cancers, like breast and liver cancer; This is a spontaneous report from a contactable consumer. A female patient of unspecified age received third dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA A VACCINE, formulation: solution for injection) via an unspecified route of administration on an unspecified date as Dose 3 (Booster), Single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection) via an unspecified route of administration on an unspecified date as Dose 1, Single and via an unspecified route of administration on an unspecified date as Dose 2, Single for COVID-19 immunization. The reporter stated that, the patient got that booster shot. On an unknown date, the reporter stated that the patient died 2 days after getting that booster. The reporter mentioned that the patient health was terrible. The reporter do not wanted to talk about patient because it was depressing. The reporter mentioned that the patient had blindness and serious cancers, like breast and liver cancer. At the time of the death, outcome of the events blindness and serious cancers, like breast and liver cancer was unknown. It was not reported if an autopsy was performed.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.; Reported Cause(s) of Death: One of them died 2 days after getting that booster
This spontaneous report as received from a Licensed Vocational Nurse refers to a patient of unknown age and gender. Concurrent or medical conditions were not reported. On 24-FEB-2015, the patient was inadvertently administered with a dose of PROQUAD (Merck), subcutaneous (dose, strength and lot number were not reported) and with a dose of VARIVAX (Merck) (dose, strength, route and lot number were not reported). No adverse effects reported. Additional information has been requested.
pt recvd vax; swollen hands & feet, red blotches all over body; no fever; tx: dph;
PT. HAD A RASH ON FINGERS AND ENTIRE BACK (CONCENTRATION ON UPPER PORTION OF BACK). RASH WAS EXTREMELY ITCHY WITH RED RAISED BUMPS AND DRY SCALEY PATCHES.
Headache, nausea, vomiting , dizziness, vertigo, muscle aches on shoulders, back, neck and abdominal
The evening of December 28, 2021 I was driving. About dusk, I realized the cars that were coming toward me I would lose them in my peripheral vision. I had headaches in the days before. I thought I was just tired. I still could not see the next day in my peripheral. Went to the eye doctor the next day. I had swelling in optic nerve. Lesions inside my eye. Needed to see retina specialist that day. Images. Hemorrhage in eye. Optic nerve swollen. Enlarged blind spot. Lesions inside of my eye. In the last few months, hemorrhaging was less and swelling was down. Blind spot would not heal. "Auto immune condition", Multi Focal Choroiditis and Panuveitis. As of today the vision has worsened and I am going back for another visit to retina specialist (MD, PHD) next week.
I was fine in the morning when I woke up and went to church. I had lunch with a friend, during lunch my throat started hurting. I was unable to donate blood as a precaution. On Monday my throat was much worse, so I made an appointment to go in and be tested for strep throat. On Tuesday I went in and had a rapid antigen COVID-19 test that came back positive. I had a headache, no fever, lost my voice for three weeks and a really bad sore throat, no cough. Little sinus drainage, no energy. I came home rested did not take any medication, just used my supplements and I am feeling much better.
patient stated he began having trouble walking. had 2 cat scans infection not confirmed but started on antibiotics anyway. patient arrived for second vaccination in a w/c. he did not need a w/c before first vaccination. family doctor recommended that he wait for a week. will reschedule 2nd vaccination w/ approval of PCP
administered slowly over 4 hours; tired; fell asleep for 2 of the 4 hours during the special dosing; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 46 year-old female patient received bnt162b2 (BNT162B2), administration date 28Sep2021 (Lot number: FE3592) at the age of 46 years as dose 2 (initial pfizer dose), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Moderna vaccine (Dose 1, anatomical location: left arm, Lot: 040B21A, NDC: Unknown, Expiration: Unknown,Dose 1, anatomical location: left arm, Lot: 040B21A, NDC: Unknown, Expiration: Unknown), administration date: 10Apr2021, when the patient was 46 years old, for Covid-19 Immunization, reaction(s): "tinging and numbness in her lower arm, hands and fingers", "tinging and numbness in her lower arm, hands and fingers", "dizziness", "bronchial asthmatic coughing", "coughing", "tiredness", "chest tightness", "tinging and numbness in her lower arm, hands and fingers and it kept getting worse and worse/bronchial asthmatic coughing was worse", "states her left arms, hands, and fingers were completely swollen", "she had no feeling", "her hands and fingers were turning blue", "Caller states two nurses came rushing out and she never got up on her own", "she woke up with full blown flu like side effects all from that Moderna shot"; Flu shot (Caller states other than the Covid Vaccines, no reactions in the past, caller she she had all her childhood vaccines in the past and she gets her flu shot every year with no issues and both pneumonia vaccines), for Immunization; Pneumonia vaccines (Caller states other than the Covid Vaccines, no reactions in the past, caller she she had all her childhood vaccines in the past and she gets her flu shot every year with no issues and both pneumonia vaccines), for Immunization. The following information was reported: WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (non-serious) with onset 28Sep2021, outcome "unknown", described as "administered slowly over 4 hours"; FATIGUE (non-serious) with onset 28Sep2021, outcome "recovered" (2021), described as "tired"; SOMNOLENCE (non-serious) with onset 28Sep2021, outcome "recovered" (28Sep2021), described as "fell asleep for 2 of the 4 hours during the special dosing". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Caller states her First Dose of the Pfizer Covid 19 Vaccine was administered slowly over 4 hours in Dr. Caller states she tolerated it well, other than being super tired and she fell asleep for 2 of the 4 hours during the special dosing.  No follow-up attempts are possible. No further information is expected.
Patient was diagnosed with herpes whitlow on June 5th. She received injection on May 21. She was treated with acyclovir 400 mg 1 po tid x 10 days. She was also treated with hydrocodone/acetaminophen 5/500 1-2 tabs Q 4-6 hours. She has rash on right arm and pain in right arm. She also had red blisters on right hand, injection given in left arm.
given FluLaval and Pediarix after being frozen; This case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a 6-month-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number 24BM2, expiry date 30th June 2022) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis, Flu Seasonal QIV Quebec (FluLaval Tetra 2021-2022 season) (batch number 24R9R, expiry date 14th May 2023) for prophylaxis and flu seasonal qiv quebec pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 3rd November 2021, the patient received Pediarix, Pediarix Pre-Filled Syringe Device, FluLaval Tetra 2021-2022 season and Flulaval Tetra Pre-Filled Syringe Device. On an unknown date, unknown after receiving Pediarix, Pediarix Pre-Filled Syringe Device, FluLaval Tetra 2021-2022 season and Flulaval Tetra Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The nurse given Pediarix, FluLaval after being frozen at minus 0.45 Celsius for 15 minutes to the patient, which led to incorrect storage of drug. The reporter consented to follow up. This case was 1 of 10 linked cases, reported by same reporter for different patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021230186:same reporter US-GLAXOSMITHKLINE-US2021230181:same reporter US-GLAXOSMITHKLINE-US2021230192:same reporter US-GLAXOSMITHKLINE-US2021230173:same reporter US-GLAXOSMITHKLINE-US2021230195:same reporter US-GLAXOSMITHKLINE-US2021230188:same reporter US-GLAXOSMITHKLINE-US2021230177:same reporter US-GLAXOSMITHKLINE-US2021230178:same reporter US-GLAXOSMITHKLINE-US2021230180:same reporter
diarrhea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Diarrhea" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DIARRHOEA (non-serious), outcome "unknown", described as "diarrhea". Therapeutic measures were taken as a result of diarrhoea. Additional information: The patient wants to know if she can resume taking antibiotics for her Diarrhea. She is taking antibiotics every two weeks but hasn't taken it yet. Patient has an appointment for the second dose of the Covid19 this Wednesday 31Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
SICK; BODY ACHE; CHILLS; LOW GRADE FEVER; NAUSEA; This spontaneous report received from a patient via other company concerned a 30 year old female of unspecified race and ethnic origin. The patient's height, and weight were not reported. The patient's concurrent conditions included: Crohn's disease. In JAN-2021, the patient experienced flare up of Crohn's disease, and in AUG-2021, it got resolved. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, intramuscular, batch number: Unknown, expiry: Unknown) dose was not reported, 1 total, administered on an unspecified date in MAY-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. Non-company suspect drugs included: Humira (adalimumab) (solution for injection in pre-filled pen, subcutaneous, batch number: Unknown, expiry: Unknown) dose and frequency were not reported from 2021 for moderate to severe adult Crohn's disease.  On an unspecified date in MAY-2021, the patient was sick and had body ache, chills, low grade fever, and nausea (dose number in series 1).  In NOV-2021, the patient's Humira pen went bad due to refrigeration purposes but it resolved on an unspecified date. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sick, body ache, chills, low grade fever, and nausea on MAY-2021 (dose number in series 1). The patient additionally received non-company covid-19 vaccine included Pfizer-Biontech (Tozinameran) (dose number in series 2) (form of administration not reported, intramuscular, batch number: Unknown, expiry: Unknown) dose was not reported, administered on an unspecified date in DEC-2021 for prophylactic vaccination.  No adverse events were reported following administration of covid-19 vaccine Pfizer-Biontech (dose number in series 2). This report was non-serious.
Too shot, developed shingles/suspected vaccination failure; shingles/ developed shingles a year later; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine at an unknown dose. On an unknown date, 1 year after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 25-Jul-2022 Reporter's comment: The case was received from the consumer via interactive digital media. The reporter reported that the patient (lady from their church) also too had the shot and developed shingles a year later. The reporter stated that the vaccine was expensive and did not work. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. The case is 1 of 5 linked cases, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR105917:Same reporter US-GLAXOSMITHKLINE-US2022AMR105921:Same reporter US-GSK-US2022AMR111697:Same reporter US-GSK-US2022AMR111698:Same reporter US-GSK-US2022AMR111699:Same reporter US-GSK-US2022AMR111700:Same reporter
Patient is currently in the hospital and is on a ventilator since yesterday. She stated she has no idea where she was exposed. Patient was brought to the hospital because she was having difficulty breathing. Patient is fully vaccinated.
Approximately 1 hour after receiving the vaccine (patient had gotten the vaccine last year with no problem) she presented with tightening of the throat (no shortness of breath), chills, body aches, red/irritated eyes, and dizziness.  The injection site showed no redness, irritation, swelling or anything whatsoever.  She took 50mg of Benadryl and remained seated on a bench next to the pharmacy.  Within an hour her chills had lessened somewhat, and her throat tightness was decreasing to the point where she could drink something and chewed on some ice chips (which she was not able to do before).  I told her that I thought she was having a reaction and to go to the emergency room for monitoring and possible epinepherine administration but she said that since she was feeling better she wanted to go home to sleep.  She's not accustomed to taking antihistamines and was tired from the Benadryl.  I sent her home with a Twin-Pak Epi-Pen with instructions on how to use it, as well as told her and her boyfriend (who was with her at the time) that if her throat starts tightening up even the slightest at all to administer the epi pen and go to the ER immediately.  Her eye redness had decreased by time she left and she said she no longer felt dizzy.
45 minutes after vaccination, I had swelling of my upper lip, mouth, face cheeks, eyes, forehead, scalp. At home I began taking antihistamines to reduce the swelling and itching. Symptoms continued for  8 days, reducing in severity each day.
Began with itchy scalp and progressed to hives / urticaria all over body. Hives move around body - flare up on one body party causing itching/burning sensation then disappear and flare up on other body parts. Hives are accompanied by dermatographia, i.e., ability to write on skin with light pressure resulting in red, raised lines that burn for 15-20 minutes and then disappear. Problem has been ongoing for approximately 11 weeks.
swollen lymph nodes that are "extremely swollen and very painful."; swollen lymph nodes that are "extremely swollen and very painful."; she has incredible pain; fever; experienced shivering that wouldn't stop; This is a spontaneous report from a contactable consumer (patient). A 58-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient was experiencing swollen lymph nodes that were "extremely swollen and very painful." She had incredible pain and it was hard for her to put her arm down or to reach forward or backwards. On 10Apr2021 she had a fever and experienced shivering that wouldn't stop. The event outcome was unknown.  No follow-up attempts are needed. information about lot/batch number cannot be obtained
Information has been received from a registered nurse concerning a 57 year old who on 17-JAN-2011 was vaccinated with a dose of VARIVAX (Merck) (lot number 666854/0163Z) instead of ZOSTAVAX (Merck) due to a human error. There was no adverse effect reported. This is one of several reports from the same source. Additional information has been requested.
Vomiting 24 hrs, nausea 36 hrs, Fatigue 48 hrs